SCHEMBL12138049

SCHEMBL12138049

CSc1ccc(-c2nc(N)nc(C)c2-c2cccnc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 5/20 0.44
▸ ADORA1 P30542 3/20 0.44
▸ RXFP1 Q9HBX9 1/20 0.43
▸ KDM4E B2RXH2 4/20 0.42
▸ HSD17B10 Q99714 2/20 0.41
▸ HTT P42858 1/20 0.41
▸ MAPT P10636 1/20 0.40
▸ TSHR P16473 2/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ HRH3 Q9Y5N1 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ CYP2A6 P11509 1/20 0.38
▸ HSP90AA1 P07900 1/20 0.38
▸ HSP90AB1 P08238 1/20 0.38
▸ PTK2 Q05397 1/20 0.38
▸ NQO2 P16083 2/20 0.37
▸ ADORA2B P29275 2/20 0.37
▸ NPY5R Q15761 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12138052 0.86 ADORA2A (0.52) ADORA2AADORA1RXFP1KDM4EHSD17B10
SCHEMBL12137635 0.85 ADORA2A (0.50) ADORA2AADORA1RXFP1KDM4EHSD17B10
SCHEMBL12137645 0.82 ADORA2A (0.44) ADORA2AADORA1RXFP1KDM4EHSD17B10
SCHEMBL12137839 0.81 MKNK1 (0.59) ADORA2AADORA1RXFP1KDM4EMAPT
SCHEMBL12137648 0.80 PTGS2 (0.53) —
SCHEMBL12137634 0.79 AXL (0.56) ADORA2AADORA1RXFP1KDM4EHSD17B10
SCHEMBL12137836 0.78 ATR (0.54) KDM4EHSD17B10HTTMAPTSMN1; SMN2
SCHEMBL12137682 0.78 KDM4E (0.45) ADORA2AADORA1RXFP1KDM4EHSD17B10
SCHEMBL12137832 0.78 KDM4E (0.45) ADORA2AADORA1RXFP1KDM4EHSD17B10
SCHEMBL12135248 0.77 ADORA2A (0.43) ADORA2AADORA1CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110281838-A1 5-ALKYNYL-PYRIMIDINES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-11-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110281838-A1 5-ALKYNYL-PYRIMIDINES MKI67, CCNA1, CCNT1 ADORA2A 314/4885ADORA1 87/4885RXFP1 3167/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback